Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Griffith

Showing results (471-480 of 565) with videos related to

Pageof 57
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2014
Pilot clinical trial of hedgehog pathway inhibitor GDC-0449 (vismodegib) in combination with gemcitabine in patients with metastatic pancreatic adenocarcinomaEdward J Kim, Vaibhav Sahai, Ethan V Abel, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|August 13, 2018
The Global Spine Care Initiative: public health and prevention interventions for common spine disorders in low- and middle-income communitiesBart N Green, Claire D Johnson, Scott Haldeman, et al.
International Journal of Radiation Oncology, Biology, Physics|February 16, 2024
Are We Missing Acute Toxicities Associated With Hypofractionated Breast Irradiation? A Report From a Large Multicenter Cohort StudyHassan Beydoun, Kent A Griffith, Reshma Jagsi, et al.
Practical Radiation Oncology|September 18, 2020
Development of an Illustrated Scale for Acute Radiation Dermatitis in Breast Cancer PatientsDean A Shumway, Nirav Kapadia, Eleanor M Walker, et al.
Chemico-Biological Interactions|March 27, 2010
Human PON1, a biomarker of risk of disease and exposureC E Furlong, S M Suzuki, R C Stevens, et al.
Breast Cancer Research and Treatment|September 13, 2005
Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapyAnne F Schott, Marilyn A Roubidoux, Mark A Helvie, et al.
Journal of Medicinal Chemistry|December 24, 2008
Discovery of 1-[9-(4-chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic acid amide hydrochloride (CP-945,598), a novel, potent, and selective cannabinoid type 1 receptor antagonistDavid A Griffith, John R Hadcock, Shawn C Black, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2012
The quality-of-life effects of neoadjuvant chemoradiation in locally advanced rectal cancerJoseph M Herman, Amol K Narang, Kent A Griffith, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 9, 2013
Demonstration of the innate electrophilicity of 4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a small-molecule positive allosteric modulator of the glucagon-like peptide-1 receptorHeather Eng, Raman Sharma, Thomas S McDonald, et al.
Scientific Reports|June 13, 2015
Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic CancerMoumita Chatterjee, Edgar Ben-Josef, Dafydd G Thomas, et al.
Pageof 57

Showing results (471-480 of 565) with videos related to

Sort By:
Pageof 57
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2014
Pilot clinical trial of hedgehog pathway inhibitor GDC-0449 (vismodegib) in combination with gemcitabine in patients with metastatic pancreatic adenocarcinomaEdward J Kim, Vaibhav Sahai, Ethan V Abel, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|August 13, 2018
The Global Spine Care Initiative: public health and prevention interventions for common spine disorders in low- and middle-income communitiesBart N Green, Claire D Johnson, Scott Haldeman, et al.
International Journal of Radiation Oncology, Biology, Physics|February 16, 2024
Are We Missing Acute Toxicities Associated With Hypofractionated Breast Irradiation? A Report From a Large Multicenter Cohort StudyHassan Beydoun, Kent A Griffith, Reshma Jagsi, et al.
Practical Radiation Oncology|September 18, 2020
Development of an Illustrated Scale for Acute Radiation Dermatitis in Breast Cancer PatientsDean A Shumway, Nirav Kapadia, Eleanor M Walker, et al.
Chemico-Biological Interactions|March 27, 2010
Human PON1, a biomarker of risk of disease and exposureC E Furlong, S M Suzuki, R C Stevens, et al.
Breast Cancer Research and Treatment|September 13, 2005
Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapyAnne F Schott, Marilyn A Roubidoux, Mark A Helvie, et al.
Journal of Medicinal Chemistry|December 24, 2008
Discovery of 1-[9-(4-chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic acid amide hydrochloride (CP-945,598), a novel, potent, and selective cannabinoid type 1 receptor antagonistDavid A Griffith, John R Hadcock, Shawn C Black, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2012
The quality-of-life effects of neoadjuvant chemoradiation in locally advanced rectal cancerJoseph M Herman, Amol K Narang, Kent A Griffith, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 9, 2013
Demonstration of the innate electrophilicity of 4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a small-molecule positive allosteric modulator of the glucagon-like peptide-1 receptorHeather Eng, Raman Sharma, Thomas S McDonald, et al.
Scientific Reports|June 13, 2015
Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic CancerMoumita Chatterjee, Edgar Ben-Josef, Dafydd G Thomas, et al.
Pageof 57